Kinase inhibition with Senexin B or MSC causes only minor effects on transcription, whereas the deletion of CDK8 significantly affects transcriptional responses and critical signaling pathways in BCR-ABL1p185+-driven leukemia. This evidence concerns the gene CDK8 and leukemia.